Vaccine is bad juju
- Thread starter Blazor
- Start date
Lily
Site Supporter
- Reaction score
- 22,337
- Location
- Pride Ally Flag
Lily
Site Supporter
- Reaction score
- 22,337
- Location
- Pride Ally Flag
I heard a distinct "swoosh" days later...
- Reaction score
- 9,326
- Reaction score
- 9,326
- Reaction score
- 9,326
- Reaction score
- 9,326
Lily
Site Supporter
- Reaction score
- 22,337
- Location
- Pride Ally Flag
- Reaction score
- 9,326
Joe
Site Supporter
- Reaction score
- 3,982
- Reaction score
- 9,326
The Prowler
Site Supporter
- Reaction score
- 3,889
- Location
- Canada
"Information about myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining outside the heart) following vaccination with these mRNA COVID-19 vaccines has been included in the labeling since 2021."
- Reaction score
- 598
- Location
- Sailing The Seas Of Cheese
And those of us who opted out of this experiment got shat on for it.
The Best Holliday
I B Best
- Reaction score
- 262
- Location
- The Best Location
LoLz at you nervous nelly alarmists.
mRNA COVID-19 vaccines have been associated with a small increase in the risk of myocarditis and pericarditis, particularly in male adolescents and young adults. This risk is rare and significantly lower than the risk of heart inflammation associated with COVID-19 infection itself.
Here's what the data suggest:
mRNA COVID-19 vaccines have been associated with a small increase in the risk of myocarditis and pericarditis, particularly in male adolescents and young adults. This risk is rare and significantly lower than the risk of heart inflammation associated with COVID-19 infection itself.
Here's what the data suggest:
- Risk is highest in young men: Myocarditis after mRNA vaccination is most commonly observed in adolescent and young adult males, particularly within 7 days of the second dose. Studies have shown reporting rates peaking in males aged 12-17 years.
- Specific vaccine and dose: Among the mRNA vaccines, the Moderna vaccine (mRNA-1273) has been associated with a higher risk of myocarditis compared to the Pfizer-BioNTech vaccine (BNT162b2) in young males. The risk is higher after the second dose than the first, and lower still after booster doses. However, some sources indicate that the risk after a booster dose remains elevated but is lower than after the second dose.
- Lower risk than COVID-19 infection: The risk of myocarditis after COVID-19 infection is significantly greater than the risk associated with vaccination. For example, one study found that COVID-19 infection was associated with an 11-fold increased risk of myocarditis in unvaccinated individuals, compared to a lower risk after vaccination.
- Mostly mild cases and favorable outcomes: Most cases of myocarditis associated with vaccination are reported to be mild, transient, and self-limiting. Patients usually recover quickly with rest and medications.
- Persistence of imaging findings: While most patients recover clinically, studies have shown that a high percentage of individuals who developed vaccine-associated myocarditis still show signs of myocardial injury on cardiac MRI scans months later. The long-term clinical and prognostic significance of these findings is currently unknown.
- The benefits of COVID-19 vaccination in preventing severe illness, hospitalization, and death from COVID-19 far outweigh the rare risk of myocarditis and pericarditis associated with the vaccine.
Similar threads
